Vpatch Cardio
Developer of a wearable cardiac arrhythmia detection system combining a 3‑lead adhesive biosensor patch, an on‑body RF transceiver with beat‑by‑beat analysis, and a cellular gateway to a secure cloud patient‑management and reporting platform. The system is designed for multi‑day ambulatory ECG monitoring, automated arrhythmia detection, and real‑time notification to clinicians. The company reports regulatory approvals for major markets and collaboration with external biosensor and biomedical engineering organisations.
Industries
Nr. of Employees
small (1-50)
Patents
Products
Wearable disposable 3‑lead ECG biosensor
Single‑use adhesive biosensor array providing diagnostic quality 3‑channel ECG signals for multi‑day wear.
Reusable on‑body RF transceiver (pod)
Small reusable RF transceiver that attaches to the biosensor, performs local beat analysis and forwards events to the cellular gateway.
Cellular gateway device
Pocketable cellular transmitter that forwards encrypted event data over GPRS/cellular networks to the cloud platform.
Cloud reporting and clinician portal
Secure web‑based application for clinician enrolment, patient management, alerting and report generation.
Wearable disposable 3‑lead ECG biosensor
Single‑use adhesive biosensor array providing diagnostic quality 3‑channel ECG signals for multi‑day wear.
Reusable on‑body RF transceiver (pod)
Small reusable RF transceiver that attaches to the biosensor, performs local beat analysis and forwards events to the cellular gateway.
Cellular gateway device
Pocketable cellular transmitter that forwards encrypted event data over GPRS/cellular networks to the cloud platform.
Cloud reporting and clinician portal
Secure web‑based application for clinician enrolment, patient management, alerting and report generation.
Services
Provision of multi‑day ambulatory ECG monitoring using a disposable adhesive biosensor array and associated reporting.
Real‑time remote monitoring and alerting service that forwards detected cardiac events to clinicians via a secure web portal.
Provision of multi‑day ambulatory ECG monitoring using a disposable adhesive biosensor array and associated reporting.
Real‑time remote monitoring and alerting service that forwards detected cardiac events to clinicians via a secure web portal.
Expertise Areas
- Ambulatory ECG monitoring
- Remote patient monitoring / mHealth
- Arrhythmia detection and clinical diagnostics
- Biosensor design and materials
Key Technologies
- Wearable adhesive 3‑lead ECG sensor
- Embedded microprocessor beat analysis
- RF transceiver for on‑body communication
- GPRS/cellular data transmission
News & Updates
Product holds CE‑Mark approval for Europe (stated since 2009).
Included in relevant Australian therapeutic goods listings (stated 2010).
FDA approval for the wearable ECG monitor (stated 2014).
Closed‑loop system reported in use across multiple countries and distributors appointed in USA and Canada.
Product holds CE‑Mark approval for Europe (stated since 2009).
Included in relevant Australian therapeutic goods listings (stated 2010).
FDA approval for the wearable ECG monitor (stated 2014).
Closed‑loop system reported in use across multiple countries and distributors appointed in USA and Canada.